Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CD274 (PD-L1) (C-Term) Peptid

PD-L1 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN974662

Kurzübersicht für CD274 (PD-L1) (C-Term) Peptid (ABIN974662)

Target

PD-L1 (CD274 (PD-L1))

Spezies

Human

Quelle

  • 6
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Sequenz

    NVTSTLRINT TTNEIFYCTF RRLDPEENHT AELVIPELPL AHPPNERTHL

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-CD274 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    PD-L1 (CD274 (PD-L1))

    Hintergrund

    CD274 is involved in the costimulatory signal, essential for T-cell proliferation and production of IL10 and IFNG, in an IL2-dependent and a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation and cytokine production.

    Alias Symbols: B7-H, B7H1, MGC142294, MGC142296, PD-L1, PDCD1L1, PDCD1LG1, PDL1

    Protein Interaction Partner: PDCD1,PDCD1

    Protein Size: 290

    Molekulargewicht

    32 kDa

    Gen-ID

    29126

    NCBI Accession

    NM_014143, NP_054862

    UniProt

    Q9NZQ7
Sie sind hier:
Chat with us!